BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 10612832)

  • 1. Somatic mosaicism in von Hippel-Lindau Disease.
    Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
    Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Hippel-Lindau disease.
    Couch V; Lindor NM; Karnes PS; Michels VV
    Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
    Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
    Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
    Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal angiomatosis and von Hippel-Lindau disease.
    Kreusel KM; Bechrakis NE; Heinichen T; Neumann L; Neumann HP; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):916-21. PubMed ID: 11148816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
    Martin R; Hockey A; Walpole I; Goldblatt J
    Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based diagnosis of the von Hippel-Lindau syndrome.
    Patel RJ; Appukuttan B; Ott S; Wang X; Stout JT
    Am J Ophthalmol; 2000 Feb; 129(2):258-60. PubMed ID: 10682986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
    Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
    Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Von Hippel-Lindau syndrome with spinal, cerebellar, and retinal hemangioblastoma in identical twins].
    Wessels T; Kemeny S; Block F
    Nervenarzt; 2002 Dec; 73(12):1195-8. PubMed ID: 12486572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study.
    Sobottka SB; Frank S; Hampl M; Schackert HK; Schackert G
    Acta Neurochir (Wien); 1998; 140(3):281-5. PubMed ID: 9638266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
    Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
    Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease.
    Piermarocchi S; Lo Giudice G; Pilotto E; Bertoja E; Scaroni C; Martella M; Opocher G; Murgia A
    Graefes Arch Clin Exp Ophthalmol; 2000 Jul; 238(7):615-20. PubMed ID: 10955664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
    Huang YR; Zhang J; Wang JD; Fan XD
    Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
    Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.